CC-4047 for Plasma cell myeloma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 105 adverse event reports in the FDA FAERS database where CC-4047 was used for Plasma cell myeloma.
Most Reported Side Effects for CC-4047
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Plasma cell myeloma | 42 | 36.8% | 35 | 9 |
| Death | 13 | 11.4% | 13 | 1 |
| Neutropenia | 10 | 8.8% | 7 | 2 |
| Thrombocytopenia | 10 | 8.8% | 6 | 3 |
| Anaemia | 8 | 7.0% | 4 | 2 |
| Pneumonia | 8 | 7.0% | 5 | 7 |
| Leukopenia | 6 | 5.3% | 3 | 2 |
| Febrile neutropenia | 5 | 4.4% | 1 | 5 |
| Neutrophil count decreased | 5 | 4.4% | 2 | 2 |
| Pancytopenia | 5 | 4.4% | 1 | 4 |
| Renal failure acute | 5 | 4.4% | 3 | 4 |
Other Drugs Used for Plasma cell myeloma
LENALIDOMIDE (273,951)
POMALIDOMIDE (81,096)
DEXAMETHASONE (49,067)
BORTEZOMIB (31,567)
DARATUMUMAB (19,119)
IXAZOMIB (17,602)
CARFILZOMIB (15,333)
THALIDOMIDE (10,689)
CYCLOPHOSPHAMIDE (9,148)
REVLIMID (7,122)